People
The Society for Clinical Research Sites announced the finalists for the 2019 Asia-Pac Site Patient Recruitment Innovation Award.
MorphoSys AG announced that its Supervisory Board has appointed Jean-Paul Kress, M.D., as its new Chief Executive Officer.
Domain Therapeutics announces the appointment of world-renowned GPCR and drug discovery and development experts to its Scientific Advisory Board (SAB): Pr. Silvio Gutkind, Pr. Morley Hollenberg and Pr. Brigitte Kieffer.
Two well-known scientists, Margaret Hamburg, co-chair of the WHO’s international advisory committee on human genome-editing, and Victor Dzau, president of the U.S. National Academy of Medicine, told STAT in separate interviews this weekend that they were extremely concerned about Denis Rebrikov’s plans.
The data indicated that some surgeons prescribed more than 100 opioid pills for the week after a surgery. However, current guidelines from several academic medical centers called for zero to 10 pills for many of the procedures analyzed, with up to 30 for coronary bypass surgery.
Two weeks after filing a lawsuit against his former company from prison, Martin Shkreli has reached a settlement with Retrophin.
Biotech and pharma companies strengthen their leadership teams and committees with new appointments.
Chief Operating Officer Dan Paterson has been appointed to the role of president and will lead the company while the board of directors conducts a search for a new CEO.
According to a report, GSK has bundled the products into three separate packets in order to attract regional buyers.
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-used Cas9.
PRESS RELEASES